SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-006558
Filing Date
2018-05-10
Accepted
2018-05-10 16:16:10
Documents
55
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 369819
2 ex31-1.htm EX-31.1 12607
3 ex31-2.htm EX-31.2 12969
4 ex32-1.htm EX-32.1 11438
  Complete submission text file 0001493152-18-006558.txt   2382039

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cocp-20180331.xml EX-101.INS 345976
6 XBRL SCHEMA FILE cocp-20180331.xsd EX-101.SCH 35611
7 XBRL CALCULATION FILE cocp-20180331_cal.xml EX-101.CAL 40378
8 XBRL DEFINITION FILE cocp-20180331_def.xml EX-101.DEF 130448
9 XBRL LABEL FILE cocp-20180331_lab.xml EX-101.LAB 244020
10 XBRL PRESENTATION FILE cocp-20180331_pre.xml EX-101.PRE 190552
Mailing Address 1860 MONTREAL ROAD TUCKER GA 30084
Business Address 1860 MONTREAL ROAD TUCKER GA 30084 (425) 398-7178
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38418 | Film No.: 18822720
SIC: 2834 Pharmaceutical Preparations